Eilean Therapeutics
Eilean Therapeutics
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human Study of ZE66-0205 in Healthy Volunteers | Healthy Volunteers (HV) | Not yet recruiting | Phase 1 | 2026-08-14 | NCT07735728 | |
| A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-07-29 | NCT07524140 | |
| Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients. | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 1 | 2026-05-11 | NCT07234864 | |
| Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, primary myelofibrosis | Not yet recruiting | Phase 1 | 2026-04-14 | NCT07529951 |